The bankruptcy underscores the great risks of investing in many of the companies that have gone public via mergers with ...

23andMe bankruptcy underscores the risk of investing in most SPACs. - MarketWatch photo illustration/iStockphoto 23andMe is going bankrupt — underscoring the great ...

Just before the 23andMe SPAC deal closed ... giving investors the impression it is a risk-free investment. Some companies do not find appropriate acquisition targets and have to redeem the ...

Learn about the rapidly growing healthtech sector, including key investment areas, potential risks and future trends, to make ...

US stocks took a massive hit on Thursday, with the Dow Jones Industrial Average tumbling more than 1,200 points, reflecting ...

In September, Newsmax announced plans to go public in early 2025. However, in a swift turn of events, the company raised $75 ...

Me collected information from survey questions about personal health and beyond, such as drinking habits and risk tolerance.

If you were a 23andMe customer, your genetic and personal information could be used in civil or criminal cases, targeted ...

Competitors like AncestryDNA and MyHeritage, both vying for customers in the at-home genetics and health space ... used by 23andMe, drawn from customer at-home testing kits, poses risks of ...